The latest price target for Pharvaris (NASDAQ:PHVS) was reported by Wolfe Research on April 9, 2026. The analyst firm set a price target for $42.00 expecting PHVS to rise to within 12 months (a possible 45.76% upside). 20 analyst firms have reported ratings in the last year.

The latest analyst rating for Pharvaris (NASDAQ:PHVS) was provided by Wolfe Research, and Pharvaris initiated their outperform rating.

The last upgrade for Pharvaris NV happened on October 9, 2025 when B of A Securities raised their price target to $27. B of A Securities previously had an underperform for Pharvaris NV.

There is no last downgrade for Pharvaris.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pharvaris, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pharvaris was filed on April 9, 2026 so you should expect the next rating to be made available sometime around April 9, 2027.

While ratings are subjective and will change, the latest Pharvaris (PHVS) rating was a initiated with a price target of $0.00 to $42.00. The current price Pharvaris (PHVS) is trading at is $28.82, which is within the analyst’s predicted range.